Syros Takes The Road Less Traveled In Gene Control, Awaits Windfall From Diverse Indications
April 25, 2018 at 14:57 PM EDT
The rising popularity of gene control is unconcerning to Syros Pharmaceuticals Inc (NASDAQ: SYRS), a company where the top line depends ...
